SOLID NANOPARTICLE FORMULATION OF MICROTUBLE INHIBITORS WITH REDUCED OSTWALD REPENING FOR ORAL ADMINISTRATION

• 收藏
• 分享

专利权人:

Luminus Biosciences; Inc.

发明人:

Chandra U. Singh

申请号：

US15106275

公开号：

US20170020817A1

申请日:

2014.12.19

申请国别(地区):

US

年份:

2017

代理人:

摘要：

The present invention belongs to the fields of pharmacology, medicine and drug delivery. The present invention provides novel pharmaceutical compositions composed of solid nanoparticles comprising microtubule inhibitor such as docetaxel, cabazitaxel and ixabepilone with reduced Ostwald ripening for oral administration.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/